Insider · CIK 0001606653
Richard T Kenney
officer
Files at SONN (Sonnet BioTherapeutics Holdings, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | DDisposition to issuer Common Stock | -9,374 | - | - | 0 | Dec 4, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | MOption exercise Common Stock | +86,505 | - | - | 86,505 | Dec 4, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | FTax withholding Common Stock | -16,891 | - | - | 69,614 | Dec 4, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | DDisposition to issuer Common Stock | -69,614 | - | - | 0 | Dec 4, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | MOption exercise Common Stock | +163,760 | - | - | 163,760 | Dec 4, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | DDisposition to issuer Common Stock | -163,760 | - | - | 0 | Dec 4, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | MOption exercise Warrant (Common Stock)derivative | -86,505 | - | - | 0 | Dec 4, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | DDisposition to issuer Warrant (Common Stock)derivative | -320,000 | - | - | 0 | Dec 4, 2025 |
| Dec 2, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | MOption exercise Series 5 Preferred Stockderivative | -200 | - | - | 0 | Dec 4, 2025 |
| Jun 30, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Warrantderivative | +86,505 | - | - | 86,505 | Aug 21, 2025 |
| Jul 14, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Warrantderivative | +320,000 | - | - | 320,000 | Aug 21, 2025 |
| Jul 14, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Series 5 Preferred Stockderivative | +200 | - | - | 200 | Aug 21, 2025 |
| Jul 11, 2025 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +8,000 | - | - | 9,374 | Jul 15, 2025 |
| Dec 11, 2023 | SONN Sonnet BioTherapeutics Holdings, Inc. | AGrant or award Common Stock | +1,271 | - | - | 1,374 | Dec 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.